COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Tumor Immunology - 1st Edition - ISBN: 9780128051566, 9780128096550

Tumor Immunology, Volume 130

1st Edition

Serial Volume Editor: Robert Schreiber
Hardcover ISBN: 9780128051566
eBook ISBN: 9780128096550
Imprint: Academic Press
Published Date: 1st March 2016
Page Count: 332
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

Chapter One: Mouse Models of Tumor Immunotherapy

  • Abstract
  • 1 Introduction
  • 2 Transplantable Tumor Models
  • 3 Genetically Engineered Tumor Models
  • 4 Carcinogen-Induced Tumor Models
  • 5 Humanized Mouse Tumor Models
  • 6 Perspectives
  • 7 Materials and Methods
  • Acknowledgments

Chapter Two: The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer

  • Abstract
  • 1 Introduction
  • 2 Cancer Immunoediting as an Encompassing Model of Immune System–Tumor Interactions
  • 3 Antigenic Targets of Cancer Immunoediting
  • 4 Setting the Groundwork: Genomic Approaches to Cancer Antigen Identification
  • 5 Developing Cancer Immunotherapies Based on Genomic Identification of Tumor-Specific Neoantigens
  • 6 Neoantigens as Therapeutic Targets in Human Cancer
  • 7 Concluding Remarks
  • Acknowledgments

Chapter Three: Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy

  • Abstract
  • 1 Rationale for Studying Regulation of the T Cell-Inflamed Tumor Microenvironment Phenotype
  • 2 Molecular and Cellular Drivers of the T Cell-Inflamed Tumor Microenvironment
  • 3 Tumor-Intrinsic Oncogene Pathways Mediating the Non-T Cell-Inflamed Tumor Microenvironment
  • 4 Environmental Factors Influencing the Tumor Microenvironment: The Host Microbiota
  • 5 Germline Genetic Differences as an Additional Source of Interpatient Heterogeneity
  • 6 Conclusions and Implications

Chapter Four: Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers

  • Abstract
  • 1 Introduction
  • 2 The Immune Microenvironment of Different Cancer Subtypes
  • 3 Classification of Tumors in the Era of Omic Techniques
  • 4 The Tumor Microenvironment and the Molecularly Defined Subgroups of Human Cancers
  • 5 Conclusions: From the Immune Contexture of Tumor Subgroups to Precision Medicine
  • Acknowledgments

Chapter Five: Advances in Therapeutic Cancer Vaccines

  • Abstract
  • 1 Introduction
  • 2 Cancer Antigens
  • 3 Approaches to Cancer Vaccines: What We Have Learned
  • 4 In Situ Vaccination
  • 5 Engineering Approaches
  • 6 Concluding Remarks

Chapter Six: Combinatorial Cancer Immunotherapies

  • Abstract
  • 1 Introduction
  • 2 Combinations of Coinhibitory Checkpoints
  • 3 Combinations with Costimulatory Checkpoints
  • 4 Combinations with Other Molecules in the Tumor Microenvironment
  • 5 Other Anticancer Treatment Modalities in Combination with T Cell Checkpoint Blockade
  • 6 Conclusions

Chapter Seven: Adoptive T-Cell Therapy for Cancer

  • Abstract
  • 1 Identifying Tumor-Associated Antigens Recognized by T-Cells
  • 2 Cell Therapy with Genetically Engineered T-Cells
  • 3 Cell Therapy with TIL
  • 4 Cell Therapy Targeting Mutated “Neoantigens”
  • 5 The Future of ACT


Advances in Immunology, a long-established and highly respected publication, presents current developments as well as comprehensive reviews in immunology. Articles address the wide range of topics that comprise immunology, including molecular and cellular activation mechanisms, phylogeny and molecular evolution, and clinical modalities. Edited and authored by the foremost scientists in the field, each volume provides up-to-date information and directions for the future.

This volume focuses on tumor immunology.

Key Features

  • Contributions from leading authorities
  • Informs and updates on all the latest developments in the field


Immunologists and infectious disease specialists, cell biologists and hematologists.


No. of pages:
© Academic Press 2016
1st March 2016
Academic Press
Hardcover ISBN:
eBook ISBN:

Ratings and Reviews

About the Serial Volume Editor

Robert Schreiber

Professor Robert Schreiber works at the Washington University in St Louis, USA.

Affiliations and Expertise

Department of Pathology and Immunology, School of Medicine, Washington University, St Louis, USA